Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AVTE Aerovate > Detailed Quotes

AVTE Aerovate

Watchlist
22.850
-0.840-3.55%
Close  01/31 16:00 ET
22.8500.0000.00%
Post Mkt Price 01/31 16:01 ET
High
24.225
Open
23.760
Turnover
679.87K
Low
22.590
Pre Close
23.690
Volume
29.50K
Market Cap
562.23M
P/E(TTM)
Loss
52wk High
30.790
Shares
24.61M
P/E(Static)
Loss
52wk Low
8.330
Float Cap
105.42M
Bid/Ask %
0.00%
Historical High
30.790
Shs Float
4.61M
Volume Ratio
0.34
Historical Low
7.740
Dividend TTM
--
Div Yield TTM
--
P/B
4.04
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.64%
Amplitude
6.90%
Avg Price
23.044
Lot Size
1
Float Cap
105.42M
Bid/Ask %
0.00%
Historical High
30.790
Shs Float
4.61M
Volume Ratio
0.34
Historical Low
7.740
Dividend TTM
--
P/B
4.04
Dividend LFY
--
Turnover Ratio
0.64%
Amplitude
6.90%
Avg Price
23.044
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.
CEO: Mr. Timothy P. Noyes
Market: NASDAQ
Listing Date: 06/30/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist